Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Excellos logo — A unique full-service CDMO, setting new standards in Cell &...

Excellos

A unique full-service CDMO, setting new standards in Cell & Gene Therapy

Founded 2021 United States San Diego, United States 38 employees Corporate Round Total: $20.00M Biotechnology, Health Care +1

General Information

Company Name Excellos
Founded Year 2021
Location United States San Diego, United States +1
Employees 38
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Corporate Round
Social

Get notified when Excellos moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Excellos

Excellos is a biotechnology startup based in the United States, founded in 2021. It operates as a unique full-service CDMO, focusing on cell and gene therapy innovation. Leveraging the expertise and resources of the San Diego Blood Bank with over 70 years of experience, Excellos aims to set a new industry standard. The company excels in collecting critical human cells and tissues and providing manufacturing and development services for the cell and gene therapy industry, with a specific focus on therapies in preclinical through phase II/III, and scalable operations for commercial use. Excellos' last investment was a $5.00M Venture Round investment on 16 August 2023. The company has been able to secure this investment without disclosing the specific investors. With its commitment to leveraging donor populations for life science research and advancing cellular therapies, Excellos is poised to contribute significantly to the healthcare industry.

Taxonomy: Cell and Gene Therapy, CDMO, cGMP Manufacturing, TIL Therapies, CAR-T Therapy, Immunotherapy, Clinical Manufacturing, Life Science Research, Human Cell and Tissue Collection, Process Development, Global Scale Operations, Donor Pool Access, San Diego Blood Bank, Institutional Expertise

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Corporate Round •••••• 1 •••• •••• 17 Jan 2024
Venture Round •••••• - 16 Aug 2023
Funding Round •••••• 1
Investor
25 Jan 2022

Excellos Alternatives & Competitors

Excellos vs
HemaCare Corporation, a Charles River Company
HemaCare Corporation, a Charles River Company United States

A Charles River Company

96 employees
Biotechnology
Compare Excellos vs HemaCare Corporation, a Charles River Company
Excellos vs
BioBridge Global
BioBridge Global United States

Our mission is to save and enhance lives through the healing power of human cells and tissue.

287 employees
Health Care
Compare Excellos vs BioBridge Global
Excellos vs
RoslinCT
RoslinCT United Kingdom

Your Advanced Cell & Gene Therapy CDMO Partner

Private Equity
350 employees
Biotechnology, Manufacturing
Compare Excellos vs RoslinCT

FAQ About Excellos

A unique full-service CDMO, setting new standards in Cell & Gene Therapy
Excellos was founded in 2021.
Excellos is headquartered in San Diego, United States.
Excellos operates in the following industries: Biotechnology, Health Care, Life Sciences.
Excellos has approximately 38 employees.
Excellos has completed 3 funding rounds, raising a total of $20.00M. The latest funding stage is Corporate Round.
Top alternatives and competitors to Excellos include HemaCare Corporation, a Charles River Company, BioBridge Global, RoslinCT, CGT Global, Cell BioEngines, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Excellos and HemaCare Corporation, a Charles River Company are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Excellos and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy